Cargando…

Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16

PURPOSE: To evaluate the impact of HPV16 load (VL—the number of virus genome copies per cell) and P16 expression on prognosis of patients with squamous cell carcinomas (SCCs) of head and neck (HN). MATERIALS AND METHODS: HPV16 presence was assessed in the group of 109 patients with HNSCCs by quantit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biesaga, Beata, Mucha-Małecka, Anna, Janecka-Widła, Anna, Kołodziej-Rzepa, Marta, Szostek, Sława, Słonina, Dorota, Kowalczyk, Aleksandra, Halaszka, Krzysztof, Przewoźnik, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756549/ https://www.ncbi.nlm.nih.gov/pubmed/29043437 http://dx.doi.org/10.1007/s00432-017-2531-2

Ejemplares similares

Active HPV infection and its influence on survival in head and neck squamous-cell cancer
por: Janecka-Widła, Anna, et al.
Publicado: (2020)

Differences between Squamous Cell Carcinomas of the Base of the Tongue and the Tonsils in Prevalence of HPV16 Infection, Its Type, and Clinical Features
por: Biesaga, Beata, et al.
Publicado: (2023)

Low frequency of HPV positivity in breast tumors among patients from south-central Poland
por: Biesaga, Beata, et al.
Publicado: (2021)

Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx
por: Biesaga, Beata, et al.
Publicado: (2022)

p16, HPV, and Cetuximab: What Is the Evidence?
por: Bonner, James A., et al.
Publicado: (2017)

Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy
por: Mucha-Małecka, Anna, et al.
Publicado: (2021)

HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus
por: Nicolás‐Párraga, Sara, et al.
Publicado: (2016)

The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression
por: Meznad, Koceila, et al.
Publicado: (2021)

Short half‐life of HPV16 E6 and E7 mRNAs sensitizes HPV16‐positive tonsillar cancer cell line HN26 to DNA‐damaging drugs
por: Wu, Chengjun, et al.
Publicado: (2018)

miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancer
por: Wang, Hui, et al.
Publicado: (2020)

Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland
por: Słonina, Dorota, et al.
Publicado: (2014)

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
por: Rosillon, Dominique, et al.
Publicado: (2019)

Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial
por: Lehtinen, Matti, et al.
Publicado: (2019)

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age
por: Schwarz, Tino F., et al.
Publicado: (2017)

A cross‐sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women
por: Wu, Qiongyan, et al.
Publicado: (2017)

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions
por: Speetjens, Frank M, et al.
Publicado: (2022)

ISA101 and nivolumab for HPV-16(+) cancer: updated clinical efficacy and immune correlates of response
por: de Sousa, Luana Guimaraes, et al.
Publicado: (2022)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

HPV Infection Significantly Accelerates Glycogen Metabolism in Cervical Cells with Large Nuclei: Raman Microscopic Study with Subcellular Resolution
por: Sitarz, Katarzyna, et al.
Publicado: (2020)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy
por: Biesaga, Beata, et al.
Publicado: (2014)

p16 in HPV-associated cancers
por: Munger, Karl, et al.
Publicado: (2013)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019)

Dynamic response of HPV16/anti-HPV16 pairs with unbinding events studied by atomic force microscopy
por: Lin, Shiming, et al.
Publicado: (2016)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

CircRNA circPDSS1 promotes bladder cancer by down-regulating miR-16
por: Yu, Qinnan, et al.
Publicado: (2020)

Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China
por: He, Hongchang, et al.
Publicado: (2016)

Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma
por: Schlecht, Nicolas F, et al.
Publicado: (2015)

Safety Assessment of Foods and Drinks Consumed by People on a Gluten-Free Diet
por: Przybylska, Anna, et al.
Publicado: (2022)

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays
por: Lin, Shih-Wen, et al.
Publicado: (2013)

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer
por: Jiang, Pengfei, et al.
Publicado: (2018)

Assessment of HPV 16, HPV 18, p16 expression in advanced stage laryngeal cancer patients and prognostic significance()()
por: Dogantemur, Selman, et al.
Publicado: (2019)

Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
por: Cittelly, Diana M., et al.
Publicado: (2010)

Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16
por: Ki, Eun Young, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qokgg482t7hqod68kbqt0as6n6